A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Experimental Drug Gaining Traction Online
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles directly for source information, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or prison.
Service Reaction and Content Removal
Based on the social media company, the platform has removed violative content and banned associated hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.
After moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, health issues or past usage.
Item Information and Pricing
Inside these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they cannot confirm. Although the research behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.
